找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

ESCI期刊GaBI Journal-Generics and Biosimilars Initiative Journal 2024/2025影响因子:0.345 (GABI J) (2033-6403). (PHARMACOLOGY

[复制链接]
楼主: Curator
发表于 2025-3-27 00:27:36 | 显示全部楼层
Submitted on: 15 February 1998. Revised on: 12 June 1998. Accepted on: 02 July 1998. ___________________GaBI Journal-Generics and Biosimilars Initiative Journal
发表于 2025-3-27 02:19:14 | 显示全部楼层
Submitted on: 18 February 2012. Revised on: 10 May 2012. Accepted on: 27 May 2012. ___________________GaBI Journal-Generics and Biosimilars Initiative Journal
发表于 2025-3-27 08:02:45 | 显示全部楼层
Submitted on: 23 July 2020. Revised on: 20 October 2020. Accepted on: 01 November 2020. ___________________GaBI Journal-Generics and Biosimilars Initiative Journal
发表于 2025-3-27 11:56:34 | 显示全部楼层
Submitted on: 08 December 2016. Revised on: 27 January 2017. Accepted on: 02 March 2017. ___________________GaBI Journal-Generics and Biosimilars Initiative Journal
发表于 2025-3-27 17:03:10 | 显示全部楼层
Submitted on: 08 May 2010. Revised on: 14 August 2010. Accepted on: 26 August 2010. ___________________GaBI Journal-Generics and Biosimilars Initiative Journal
发表于 2025-3-27 20:09:48 | 显示全部楼层
Submitted on: 12 November 2018. Revised on: 15 February 2019. Accepted on: 23 March 2019. ___________________GaBI Journal-Generics and Biosimilars Initiative Journal
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-8 03:43
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表